PAXOLL is contraindicated in patients who have a history of hypersensitivity reactions to PAXOLL or other drugs formulated in polyoxyethylated castor oil. PAXOLL should not be used in patients with solid tumors who have baseline neutrophil counts of <1500 cells/mm3 or in patients with AIDS-related Kaposi's sarcoma with baseline neutrophil counts of <1000 cells/mm3.
Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
